You have 9 free searches left this month | for more free features.

pRBC

Showing 26 - 50 of 198

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Beta-Thalassemia Trial in Worldwide (LentiGlobin BB305 Drug Product)

Active, not recruiting
  • Beta-Thalassemia
  • LentiGlobin BB305 Drug Product
  • Oakland, California
  • +8 more
Feb 4, 2022

Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in

Recruiting
  • Autoimmune Hemolytic Anemia
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Aortic Regurgitation Trial in Beijing (TaurusTrio™ Heart Valve System)

Recruiting
  • Aortic Regurgitation
  • TaurusTrio™ Heart Valve System
  • Beijing, China
    首都医科大学附属北京安贞医院
Oct 20, 2023

Cancer, Tumour, Surgery Trial in Canada, United States (Tranexamic acid (TXA), Normal saline)

Active, not recruiting
  • Cancer
  • +2 more
  • Tranexamic acid (TXA)
  • Normal saline
  • Rochester, Minnesota
  • +10 more
Oct 25, 2022

MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

Recruiting
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Darbepoetin Alfa
  • Tampa, Florida
    Moffitt Cancer Center
Nov 21, 2022

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen Children's Hospital
Feb 24, 2023

Sickle Cell Disease Trial in Birmingham, Palo Alto, Saint Louis (GPH101 Drug Product)

Active, not recruiting
  • Sickle Cell Disease
  • GPH101 Drug Product
  • Birmingham, Alabama
  • +2 more
Jan 5, 2023

Warm Autoimmune Hemolytic Anemia Trial in Riverside (ALXN1830, Placebo)

Withdrawn
  • Warm Autoimmune Hemolytic Anemia
  • Riverside, California
    Clinical Study Site
Feb 2, 2022

Sickle Cell Disease Trial in United States (bb1111)

Recruiting
  • Sickle Cell Disease
  • bb1111
  • Birmingham, Alabama
  • +8 more
Jul 15, 2022

Mild to Moderate Acute Respiratory Distress Syndrome Trial in France (PrismaLung+)

Recruiting
  • Mild to Moderate Acute Respiratory Distress Syndrome
  • PrismaLung+
  • Besançon, France
  • +8 more
Dec 29, 2022

Paroxysmal Hemoglobinuria, Nocturnal Trial in Worldwide (Crovalimab, Placebo)

Active, not recruiting
  • Paroxysmal Hemoglobinuria, Nocturnal
  • Paris, France
  • +18 more
Dec 5, 2022

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

ß-thalassemia Trial in Shanghai (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • Shanghai, China
    Shanghai Ruijin Hospital
Mar 16, 2023

Evaluate the Impact of Eculizumab in Korean PNH Patients

Completed
  • PNH
    • Seoul, Korea, Republic of
      Handok
    Apr 14, 2022

    MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

    Recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Luspatercept Injection [Reblozyl]
    • Alessandria, Italy
    • +22 more
    Jun 20, 2023

    Aortic Valve Replacement Trial in China (EDWARDS INSPIRIS RESILIA Aortic Valve)

    Recruiting
    • Aortic Valve Replacement
    • EDWARDS INSPIRIS RESILIA Aortic Valve
    • Xiamen, Fujian, China
    • +5 more
    Oct 19, 2022

    Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Hemoglobinuria Trial in Worldwide (Pegcetacoplan)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Paroxysmal Hemoglobinuria
    • Atlanta, Georgia
    • +9 more
    Jul 18, 2022

    MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

    Completed
    • Myelodysplastic Syndromes
    • Thrombocytopenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 8, 2022

    Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD Trial run by the National Heart, Lung, and Blood

    Not yet recruiting
    • Immune Mediated Anemia
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Fanconi Anemia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

    Recruiting
    • Fanconi Anemia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

    Not yet recruiting
    • Carcinoma, Renal Cell
    • Pittsburgh, Pennsylvania
      UPMC Department of Urology
    Jan 5, 2023

    Intraoperative Transfusion Practice in Children

    Completed
    • Transfusion
      • Frankfurt, NRW, Germany
        Department of Anaesthesiology, Intensive Care Medicine and Pain
      Aug 23, 2021

      Burns Trial in Riyadh (Enoxaparin 40 mg q24 hours, Enoxaparin 30 mg q12 hours, Unfractionated heparin 5000 U q8 hours)

      Completed
      • Burns
      • Enoxaparin 40 mg q24 hours
      • +2 more
      • Riyadh, Saudi Arabia
        King Abdulaziz Medical City
      Dec 17, 2022

      Cold Agglutinin Disease Trial in Whittier, Miami Lakes (Pegcetacoplan)

      Recruiting
      • Cold Agglutinin Disease
      • Whittier, California
      • +1 more
      Mar 8, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074, Soliris)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • (no location specified)
      Jan 17, 2023